Centre for Neuromuscular Disease
- Home
- Clinical Services
- Core Activities
- Animal Models
- Biobanking
- Clinical Trials
- Imaging
- Teaching
- Research Groups
- MRC Centre Members
- Scientific Advisory Board
- Publications
- Seminar Program
- UK Neuromuscular Translational Research Conference
- Courses and Workshops
- Studentships
- Fellowships
- Clinical Trials
- The UK National Neuromuscular Database
- Dubowitz Neuromuscular Centre
- Cochrane Neuromuscular Disease Group
- British Myology Society
- British Peripheral Nerve Society
- Industry Collaborations
- Patient Organisation Partners
- Donations
- Job Vacancies
- UK Neuromuscular Translational Research Conference 2011
- UK Neuromuscular Translational Research Conference 2010
- UK Neuromuscular Translational Research Conference 2009
- Inaugural UK Neuromuscular Translational Research Conference 2008
- Contact Us
Contacts
CNMD Biobank London
Diana Johnson
Tel: +44 (0)20 7905 2221
Email: d.johnson@ich.ucl.ac.uk
CNMD Biobank Newcastle
Mojgan Reza
Tel. +44 (0)191 282 8834
Email: mojgan.reza@newcastle.ac.uk
Biobanking
The rarity and genetic heterogeneity of neuromuscular disorders (NMD) has hampered the understanding of their pathogenesis and the development of therapies. The lack of access to patient tissue and patient derived primary cell cultures for many basic scientists has also slowed down progress. Recent advances have led to the discovery of the majority of the genes responsible for NMDs and to the elucidation of mechanisms involved in these diseases, which could be targeted by specific intervention. In order to take advantage of the large neuromuscular patient population seen at the MRC Centre in London and Newcastle, and to facilitate the translational research activities of the Centre, we have decided to create a repository of human muscle and non-muscle cells from patients with NMD (biobank). In particular we intend to collect tissues and primary cell cultures from skin; muscle; stem cells; and nerve from patients with genetically determined NMDs. A number of projects already initiated (such as the antisense oligonucleotide approach to induce exon skipping in Duchenne muscular dystrophy) are dependent on the availability of such cell cultures and future projects will use this material to investigate biomarkers predictive of therapeutic response in therapeutic trials and analyse the stratification of response.
The ultimate goal of this biobank is to provide an ethically robust and durable framework to collect unique material and make it available to investigators involved in the MRC Centre, but also facilitate access to collections by UK partners and other EU partners. Similar biobanks already exist in other EU countries, and this new MRC initiative will work in partnership with the European Network Eurobiobank, which, together with the EU Network of Excellence TREAT-NMD, will facilitate collaboration and translational research in UK and Europe.
